Download DNB 2020 December Nuclear MedIcIne Paper II Question Paper

Download Diplomate of National Board (DNB) 2020 December Nuclear MedIcIne Paper II Question Paper

FINAL EXAM
NATIONAL BOARD OF EXAMINATIONS
DECEMBER 2020
NUCLEAR MEDICINE
PAPER-II

Time: 3 hours
NM/D/20/24/II
Max. Marks:100
Important Instructions:
You are provided with 5 answer sheet booklets. Each individual answer sheet booklet consists
of 10 pages excluding the covering jackets.
Answers to all the questions must be attempted within these 5 answer sheet booklets which
must be later tagged together at the end of the exam.
No additional supplementary answer sheet booklet will be provided.
Attempt all questions in order.
Each question carries 10 marks.
Read the question carefully and answer to the point neatly and legibly.
Do not leave any blank pages between two answers.
Indicate the question number correctly for the answer in the margin space.
Answer all the parts of a single question together.
Start the answer to a question on a fresh page or leave adequate space between two answers.
Draw table/diagrams/flowcharts wherever appropriate.

Write short notes on:

1. a) 18F-FET vs. 18F-FDOPA in glial tumors.
5+5
b) Why F18 Sodium Fluoride bone scan is not able to replace Tc99m
MDP bone scan?
2. a) LAL test .
5+5
b) Swipe test.
3. What are the principles radionuclide generators in nuclear medicine?
7+3
Describe the various PET radionuclide producing generators.
4. Name the various available bone pain palliation agents for the Indian
6+4
patients. What are the emerging radiopharmaceuticals for similar
applications?
5. a) 18F-Choline vs. 99mTc-Sestemibi.
5+5
b) 18F-Fluciclovine vs. 68Ga-PSMA11.
6. Name useful alpha-emitters currently available and their characteristics.
7+3
Why in India we are not able to produce such radionuclides?
7. Describe various bi-functional chelators. Justify how twenty-first century
5+5
radiochemistry has been changed due to such chelants.
8. Name various peptide-based radiopharmaceuticals and describe one in
5+5
details.
9. a) Imaging agents for insulinoma.
5+5
b) Imaging agents for Neuroblastoma.
10.
Describe the imaging artefacts in SPECT and SPECT/CT. How will you
7+3
avoid or minimize them?
*************

POSSESSION/USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE
EXAMINATION HALL.

---